Korean Diabetes J.  2010 Apr;34(2):77-83. 10.4093/kdj.2010.34.2.77.

Cell Replacement and Regeneration Therapy for Diabetes

• Jun HS

• KMID: 2222380
• DOI: http://doi.org/10.4093/kdj.2010.34.2.77

Abstract

Reduction of beta cell function and a beta cell mass is observed in both type 1 and type 2 diabetes. Therefore, restoration of this deficiency might be a therapeutic option for treatment of diabetes. Islet transplantation has benefits, such as reduced incidence of hypoglycemia and achievement of insulin independence. However, the major drawback is an insufficient supply of islet donors. Transplantation of cells differentiated in vitro or in vivo regeneration of insulin-producing cells are possible approaches for beta cell/islet regenerative therapy. Embryonic and adult stem cells, pancreatic ductal progenitor cells, acinar cells, and other endocrine cells have been shown to differentiate into pancreatic beta cells. Formation of fully functional beta cells and the safety of these cells are critical issues for successful clinical application.

Keyword

Beta cell; Diabetes mellitus; Differentiation; Islets of Langerhans; Regeneration; Stem cells

MeSH Terms

Achievement
Acinar Cells
Adult Stem Cells
Diabetes Mellitus
Endocrine Cells
Humans
Hypoglycemia
Incidence
Insulin
Insulin-Secreting Cells
Islets of Langerhans
Islets of Langerhans Transplantation
Pancreatic Ducts
Regeneration
Stem Cells
Tissue Donors
Transplants
Insulin